AYTU

Aytu Biopharma Inc.

Price

$2.26

return (12m)

-1.25%

p/e

-0.75

p/bv

0.72

DIVIDEND YIELD

0.00%

AYTU price

Aytu Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AYTU

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

5.11%

3 months

-1.31%

1 year

-1.25%

2 years

-6.23%

5 years

-96.94%

10 years

-100.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AYTU

Valuation

P/E

-0.75

Sector -0.16

Industry 2.77

P/BV

0.72

Sector 1.93

Industry 2.37

P/Revenue (PSR)

0.45

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

0.23

Sector 0.91

Industry 1.07

P/Net Current Assets

-3.61

Sector -24.70

Industry -5.25

P/Working Capital

3.45

Sector -5.32

Industry 3.11

EPS

-3.10

Sector -0.79

Industry -0.61

BVPS

3.19

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

64.78%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-26.77%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-60.17%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.11

Sector 0.13

Industry 0.15

Profitability

ROE

-96.90%

Sector -31.93%

Industry -27.86%

ROA

-30.49%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.12

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

0.27

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.27

Sector -0.72

Industry 0.10

Equity/Assets

0.31

Sector 0.43

Industry 0.45

Liabilities/Assets

0.67

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

-7.14%

Sector -

Industry -

5Y Earnings CAGR

-16.50%

Sector -

Industry -

Fundamentals AYTU

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AYTU Aytu Biopharma Inc.	$2.26	-3.00%	0.00%	-0.75	0.72	-96.90%	-60.17%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.42%	15.92	4.50	28.24%	14.54%
CRMD CorMedix Inc.	$8.22	-41.87%	0.00%	3.45	1.40	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$21.77	-28.60%	0.00%	12.05	1.23	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.12	-14.31%	0.68%	27.69	2.50	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
NVS Novartis AG	$153.04	22.95%	1.96%	28.21	7.75	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	33.36	4.42	13.26%	15.08%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
DHR Danaher Corporation	$215.43	5.71%	0.67%	37.88	2.88	7.61%	15.95%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AYTU Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Aytu Biopharma

Aytu Biopharma Inc.

Average Investor10 user rating

4.0 (2 people)

United States

24 years

Founded: 2002

2008

Time since IPO - 18 years

175

Employees

Aytu Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $25.41 million, with shareholders equity totaling $35.14 million.

The company employs approximately 175 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Aytu Biopharma Inc. reported $56.59 million in revenue, generating net income of $-34.05 million.

Key financial metrics include a P/E ratio of -0.75, a price-to-book (P/B) ratio of 0.72, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AYTU.

Market cap

$25.41 million

Net worth

$35.14 million

$35,140,000.00

Assets

$111.69 million

$111,690,000.00

Total Shares Outstanding

11.00 million

11,000,000

Average Daily Trading Volume

$26.20 Thousand

$26,195.60

Sector

Health

Industry

Pharmaceutical Products

AYTU

AYTU revenue and profits

Financial Results AYTU

DRAG THE FRAME TO SEE MORE DATA

AYTU cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75